Clinical Trials

617 enrolled 29 charts 2 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT00980954 2025-12-31

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

236 enrolled 28 charts

Uterine Cervical Neoplasms

NCT04982237 2025-11-19

A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

445 enrolled

Uterine Cervical Neoplasms

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT05179239 2025-04-15

A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

Phase 3 Terminated

31 enrolled

Uterine Cervical Neoplasms

NCT03556839 2025-01-08

BEATcc

410 enrolled

Carcinoma, Uterine Cervical Neoplasms

NCT01566240 2024-12-05

INTERLACE

500 enrolled

Uterine Cervical Neoplasms

NCT04723875 2024-11-01

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

306 enrolled

Uterine Cervical Neoplasms

NCT02584478 2023-11-08

AL3818

294 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT03534713 2023-09-21

ONCOCOL01

Phase 3 Recruiting

310 enrolled

Uterine Cervical Neoplasms

NCT05446883 2022-11-30

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

498 enrolled

Uterine Cervical Neoplasms

NCT01414608 2022-11-07

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

926 enrolled 13 charts

Uterine Cervical Neoplasms

NCT05384366 2022-05-20

Neoadjuvant Chemotherapy in Cervical Cancer

33 enrolled

Uterine Cervical Neoplasms, Neoplasms

NCT05367206 2022-05-10

N6C

Phase 3 Recruiting

280 enrolled

Uterine Cervical Neoplasms

NCT04806945 2022-05-05

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT03912415 2020-09-18

FERMATA

316 enrolled

Uterine Cervical Neoplasms

NCT02629718 2018-03-16

SYSGO-003

700 enrolled

Uterine Cervical Neoplasms

NCT01461772 2017-05-31

Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Phase 3 Terminated

21 enrolled

Uterine Cervical Neoplasms

NCT02036164 2017-04-06

ACT-LACC

500 enrolled

Uterine Cervical Neoplasms

NCT00295789 2016-09-22

Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

253 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT02422563 2015-04-21

NACOPRAD

534 enrolled